As on Wednesday, Chromadex Corp (NASDAQ: CDXC) started slowly as it slid -3.31% to $7.01, before settling in for the price of $7.25 at the close. Taking a more long-term approach, CDXC posted a 52-week range of $1.32-$7.58.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Consumer Defensive Sector giants’ yearly sales growth during the last 5-year period was 22.27%. Meanwhile, its Annual Earning per share during the time was 35.83%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 157.14%. This publicly-traded company’s shares outstanding now amounts to $74.98 million, simultaneously with a float of $48.22 million. The organization now has a market capitalization sitting at $535.45 million. At the time of writing, stock’s 50-day Moving Average stood at $4.06, while the 200-day Moving Average is $3.17.
Chromadex Corp (CDXC) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Packaged Foods industry. Chromadex Corp’s current insider ownership accounts for 36.88%, in contrast to 21.98% institutional ownership. According to the most recent insider trade that took place on Aug 23 ’24, this organization’s Director sold 23,000 shares at the rate of 3.57, making the entire transaction reach 82,110 in total value, affecting insider ownership by 0.
Chromadex Corp (CDXC) Earnings and Revenue Records
Chromadex Corp’s EPS increase for this current 12-month fiscal period is 157.14% and is forecasted to reach 0.13 in the upcoming year.
Chromadex Corp (NASDAQ: CDXC) Trading Performance Indicators
Let’s observe the current performance indicators for Chromadex Corp (CDXC). It’s Quick Ratio in the last reported quarter now stands at 2.35. The Stock has managed to achieve an average true range (ATR) of 0.47. Alongside those numbers, its PE Ratio stands at $370.90, and its Beta score is 2.08. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.84. Similarly, its price to free cash flow for trailing twelve months is now 134.87.
In the same vein, CDXC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.02, a figure that is expected to reach 0.02 in the next quarter, and analysts are predicting that it will be 0.13 at the market close of one year from today.
Technical Analysis of Chromadex Corp (CDXC)
Through scrutinizing the latest numbers posted by the [Chromadex Corp, CDXC], it can be observed that its last 5-days Average volume of 1.33 million was better the volume of 0.53 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 91.59% While, its Average True Range was 0.55.
Raw Stochastic average of Chromadex Corp (CDXC) in the period of the previous 100 days is set at 89.19%, which indicates a major rise in contrast to 86.20% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 217.82% that was higher than 105.51% volatility it exhibited in the past 100-days period.
